Rossari Biotech Ltd (BOM:543213)
₹ 819.65 -3.05 (-0.37%) Market Cap: 45.28 Bil Enterprise Value: 45.75 Bil PE Ratio: 44.71 PB Ratio: 4.31 GF Score: 80/100

Q4 2023 Rossari Biotech Ltd Earnings Call Transcript

May 02, 2023 / 11:30AM GMT
Release Date Price: ₹695.2 (+0.99%)
Operator

Ladies and gentlemen, good day, and welcome to the Rossari Biotech Limited Earnings Conference Calls. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Ms. Aesha Shah from CDR India. Thank you, and over to you.

Aesha Shah

Good evening, everyone, and thank you for joining us on Rossari Biotech Limited's Q4 and FY '23 earnings conference call. We have with us with us, Mr. Edward Menezes, Promoter and Executive Chairman; Mr. Sunil Chari, Promoter and Managing Director; Mr. Ketan Sablok, Group Chief Financial Officer; and Ms. Manasi Nisal, Chief Financial Officer.

We will begin the call with the opening remarks from the management, following which we will have the forum open for question-and-answer session. Before we start, I would like to point out that some statement made in today's call may be forward looking in nature, and a disclaimer to this effect have been included in the earnings presentation shared with you earlier.

I would now like to invite Mr. Edward Menezes to make his

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot